CRISPR Therapeutics AG
USD52.08
+0.06 (+0.12%)
CEO
Samarth Kulkarni
IPO Date
2016-10-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CH
Open
$51.29
Prev. Close
$52.02
Day Low
$50.52
Day High
$52.28
52W Low
$37.02
52W High
$78.48
Market Cap
$5.02B
Volume
1.27M
| 3,786 |
| $55.62 |
| 1 Jun 2026 | Patel Naimish | Chief Medical Officer | M-Exempt | Disposed | 10,000 | $0.00 |
| 24 Mar 2026 | KASINGER JAMES R. | General Counsel and Secretary | M-Exempt | Acquired | 6,250 | $0.00 |
| 24 Mar 2026 | KASINGER JAMES R. | General Counsel and Secretary | S-Sale | Disposed | 3,182 | $46.78 |
| 24 Mar 2026 | KASINGER JAMES R. | General Counsel and Secretary | A-Award | Acquired | 38,499 | $46.24 |
| 24 Mar 2026 | KASINGER JAMES R. | General Counsel and Secretary | A-Award | Acquired | 25,000 | $0.00 |
| 24 Mar 2026 | KASINGER JAMES R. | General Counsel and Secretary | M-Exempt | Disposed | 6,250 | $0.00 |
| 24 Mar 2026 | Kulkarni Samarth | director, officer: Chief Executive Officer | M-Exempt | Acquired | 19,687 | $0.00 |
| 24 Mar 2026 | Kulkarni Samarth | director, officer: Chief Executive Officer | S-Sale | Disposed | 10,020 | $46.78 |
| $15,001 - $50,000 |
| 8 Nov 2017 | James Inhofe | James Inhofe | Purchase | $15,001 - $50,000 |
| Disclosed | Representative | Office | Type | Amount |
|---|---|---|---|---|
| 5 Oct 2021 | Thomas Suozzi | Thomas Suozzi | Sale (Full) | $50,001 - $100,000 |
| 19 Feb 2021 | Marjorie Taylor Greene | Marjorie Taylor Greene | Purchase | $1,001 - $15,000 |